The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-(6-oxo-1,6-dihydropyridin-3-yl)-1H-pyrazol-3-yl)urea ID: ALA2207435
Chembl Id: CHEMBL2207435
PubChem CID: 136216700
Max Phase: Preclinical
Molecular Formula: C23H25N7O2
Molecular Weight: 431.50
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(-c3ccc(=O)[nH]c3)[nH]n2)cc1
Standard InChI: InChI=1S/C23H25N7O2/c1-14-5-8-16(9-6-14)30-20(12-18(29-30)23(2,3)4)26-22(32)25-19-11-17(27-28-19)15-7-10-21(31)24-13-15/h5-13H,1-4H3,(H,24,31)(H3,25,26,27,28,32)
Standard InChI Key: LRKLKILXHVLBOT-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 431.50Molecular Weight (Monoisotopic): 431.2070AlogP: 4.20#Rotatable Bonds: 4Polar Surface Area: 120.49Molecular Species: NEUTRALHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.87CX Basic pKa: 2.02CX LogP: 4.12CX LogD: 4.10Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.39Np Likeness Score: -1.82
References 1. Bhattacharya SK, Aspnes GE, Bagley SW, Boehm M, Brosius AD, Buckbinder L, Chang JS, Dibrino J, Eng H, Frederick KS, Griffith DA, Griffor MC, Guimarães CR, Guzman-Perez A, Han S, Kalgutkar AS, Klug-McLeod J, Garcia-Irizarry C, Li J, Lippa B, Price DA, Southers JA, Walker DP, Wei L, Xiao J, Zawistoski MP, Zhao X.. (2012) Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors., 22 (24): [PMID:23153798 ] [10.1016/j.bmcl.2012.10.039 ]